Targeted exchange of an expression cassette encoding cyclooxygenase-2 at the Ptgs1 locus

Prostaglandins & Other Lipid Mediators
XinZhi LiColin D Funk

Abstract

Defining the multi-faceted roles of prostaglandins has been facilitated by studying mice with manipulated expression of the two enzymes encoding cyclooxygenase (COX) via gene targeting, with either knocked down expression of COX-1 or COX-2, a knocked-in COX-2 active site mutation and exchange of COX isoforms by insertion of a cassette encoding COX-1 into the COX-2 (Ptgs2) gene to create COX-1>COX-2 mice. Here, we sought to extend these studies by creating a new induced mutant strain with manipulated COX expression. We carried out gene targeting at the Ptgs1 locus to knock-in an expression cassette encoding COX-2 under Ptgs1 regulatory elements in a manner analogous used in COX-1>COX-2 targeting. While successful gene targeting at the Ptgs1 locus was achieved, the strategy did not yield a "basal" increase of COX-2 under Ptgs1 gene regulatory control in various cells and tissues from COX-2>COX-1 mice but rather resulted in a Ptgs1 null allele. Possible explanations as to why this strategy was unsuccessful include non-functionality of the hybrid signal peptide and aberrant transcript processing. Since a similar strategy had previously worked (i.e. COX-1 cDNA knocked-in to the Ptgs2 locus; COX-1>COX-2 mice) interpretations of our f...Continue Reading

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T Hla, K Neilson
Dec 15, 1989·Biochemical and Biophysical Research Communications·C Yokoyama, T Tanabe
Apr 18, 1998·Proceedings of the National Academy of Sciences of the United States of America·E N JohnsonC D Funk
May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
Aug 31, 2000·Annual Review of Biochemistry·W L SmithR M Garavito
Jun 20, 2001·The Journal of Clinical Investigation·W L Smith, R Langenbach
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono
Jan 5, 2002·The New England Journal of Medicine·C M Nzerue
Aug 20, 2004·Pharmacological Reviews·Daniel L SimmonsTimothy Hla
Aug 30, 2005·Biochemical and Biophysical Research Communications·K Lamar Turepu Roos, Daniel L Simmons
Jan 6, 2006·The Journal of Clinical Investigation·Tilo GrosserGarret A FitzGerald
Nov 18, 2006·The Journal of Biological Chemistry·Ying YuColin D Funk
Nov 22, 2007·Journal of Cardiovascular Pharmacology·Colin D Funk, Garret A FitzGerald
Jan 22, 2008·The Journal of Biological Chemistry·Uri R MbonyeWilliam L Smith
Apr 10, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Francesca SetaColin D Funk
Sep 18, 2009·The Journal of Biological Chemistry·Masayuki WadaWilliam L Smith

❮ Previous
Next ❯

Citations

Nov 20, 2016·PloS One·Daniel Björk WilhelmsDavid Engblom
Nov 29, 2017·Journal of Lipid Research·Xinzhi LiColin D Funk
Nov 6, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Ting WangGuangrui Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.